课题基金 / 基金详情

EXON-SPECIFIC FIBRONECTIN ISOFORMS AND CHONDROGENESIS

EXON-SPECIFIC FIBRONECTIN ISOFORMS AND CHONDROGENESIS
外显子特异性纤连蛋白异构体和软骨形成
批准号:
6648493
负责人:
Noreen J Hickok
金额:
$27.52万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-07-01 至 2005-06-30

项目摘要

项目成果

Noreen J Hickok的其他基金

相似基金

相关文献

中文摘要
翻译
纤维连接蛋白是组织细胞外基质中的连接分子,在胚胎肢体发育过程中,间质向软骨分化的软骨形成过程中,纤维连接蛋白的结构发生了变化。纤连蛋白同工型的改变是由纤连蛋白基因(IIIB, IIIA和V)中至少三个外显子的mRNA选择性剪接事件引起的。在软骨形成过程中,纤维连接蛋白mRNA剪接模式从不稳定间质中的B+A+V+转变为软骨中的B+A-V+。由外显子IIIA编码的区域在软骨形成过程中发生冷凝事件后从间充质纤维连接蛋白中消失。这种结构上的变化可能反过来导致功能上的变化。我们最近的研究表明,在高密度肢体间充质微团培养物中添加一种针对外显子IIIA编码区域的单克隆抗体,可能通过干扰细胞凝聚的形成和/或维持来抑制软骨形成。我们计划验证由mRNA选择性剪接产生的特定纤维连接蛋白异构体对软骨发育的不同阶段是必要的这一假设。前4个目标将关注间充质纤维连接蛋白的结构,特别是外显子IIIA编码的区域,是否在软骨形成过程中发生的间充质凝聚事件的某些方面是必需的。Aim 1的实验将研究在存在和不存在外显子特异性抗体和肽的情况下,细胞粘附试验中间充质细胞与各种纤维连接蛋白亚型的相互作用。目的2将通过迁移试验和聚集试验确定间充质纤维连接蛋白是否支持间充质细胞迁移和/或聚集事件参与软骨凝聚。目的3将评估纤维连接蛋白同型体对间充质细胞发育的影响,特别是与细胞密度的依赖性和n -钙粘蛋白介导的细胞间相互作用可能的功能交叉有关。目的4将通过表征tgf - β 1与软骨调节活性的功能关系来研究纤维连接蛋白亚型特异性对间充质软骨形成的调节作用。最终目标(aim 5)将通过表征纤维连接蛋白与分化软骨细胞的相互作用及其对软骨细胞表型维持的影响,开始研究软骨纤维连接蛋白(B+A+V+)中外显子IIIA缺失的生物学意义。从这些实验中得到的信息将进一步加深我们对纤维连接蛋白在软骨形成的不同阶段的功能的理解,并为在软骨发育过程中以组织特异性方式展示的纤维连接蛋白基因中可选剪接事件的目的提供有用的见解。
英文摘要
The structure of fibronectin, a connecting molecule in the extracellular matrices of tissues, changes during chondrogenesis, the differentiation of mesenchyme into cartilage, in the developing embryonic limb. Fibronectin isoform-changes result from mRNA alternative splicing events involving at least three exons in the fibronectin gene (IIIB, IIIA, and V). During chondrogenesis, the fibronectin mRNA splicing patterns change from B+A+V+ in precartilage mesenchyme to B+A-V+ in cartilage. The region encoded by exon IIIA disappears from mesenchymal fibronectin just after the condensation event that occurs during chondrogenesis. This structural change may in turn dictate a change in function. Our most recent studies show that addition of a monoclonal antibody specific for the region encoded by exon IIIA to high-density limb mesenchymal micromass cultures inhibits chondrogenesis, possibly by interfering with the formation and/or maintenance of cellular condensations. We plan to test the hypothesis that a specific fibronectin isoform resulting from mRNA alternative splicing is necessary for different stages of cartilage development. The first 4 aims will focus on whether the structure of mesenchymal fibronectin, specifically the region encoded by exon IIIA, is required for some aspect of the mesenchymal condensation event that occurs during chondrogenesis. Experiments in Aim 1 will investigate the interactions of mesenchymal cells with various fibronectin isoforms in cell adhesion assays in the presence and absence of exon-specific antibodies and peptides. Aim 2 will determine whether mesenchymal fibronectin supports mesenchymal cell migration and/or aggregation events involved in chondrogenic condensation using migration assays and aggregation assays. Aim 3 will assess the effect of fibronectin isoforms on mesenchymal condrogenesis, particularly related to the dependence on cell density and possible functional cross-talk with N-cadherin mediated cell-cell interactions. Aim 4 will examine the regulation of fibronectin isoform-specific effects on mesenchymal chondrogenesis by characterizing the functional relationship with the chondro- regulatory activities of TGF-beta1. The final aim (Aim 5) will begin to investigate the biological significance of the loss of exon IIIA in cartilage fibronectin (B+A+V+) by characterizing fibronectin interactions with differentiated chondrocytes and their effects on the maintenance of the chondrocyte phenotype. The information resulting from these experiments will further our understanding of the function of fibronectin at different stages of chondrogenesis and provide useful insights into the purpose for alternative splicing events in the fibronectin gene that are exhibited in a tissue-specific manner during cartilage development.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The joint environment and periprosthetic joint infection
  • 批准号:
    10744580
  • 项目类别:
  • 资助金额:
    $68.31万
  • 财政年份:
    2023
  • 负责人:
    Noreen J Hickok
  • 依托单位:
Synovial Fluid and Joint Sepsis
  • 批准号:
    10183167
  • 项目类别:
  • 资助金额:
    $44.1万
  • 财政年份:
    2017
  • 负责人:
    Noreen J Hickok
  • 依托单位:
Synovial Fluid and Joint Sepsis
  • 批准号:
    9402991
  • 项目类别:
  • 资助金额:
    $54.05万
  • 财政年份:
    2017
  • 负责人:
    Noreen J Hickok
  • 依托单位:
Core--Morphology and biomechanics
  • 批准号:
    6592113
  • 项目类别:
  • 资助金额:
    $15.53万
  • 财政年份:
    2002
  • 负责人:
    Noreen J Hickok
  • 依托单位:
海外基金